Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Features
This article addresses conflicting court decisions on the extent to which an insured's allegations of insurer bad faith eviscerate the insurer's attorney-client privilege.
The vacuum of information concerning risks posed by nanotechnology and nanomaterials makes risk management planning difficult, if not impossible. This article addresses that gap and explores the insurance implications of the likely "first wave" of lawsuits — suits arising out of exposure to nanomaterials in the absence of evidence of actual physical injury or harm.
Torturing, maiming, decapitating and urinating on human beings are rare topics in U.S. Supreme Court arguments. But the justices on Nov. 2 heard all of them as they entered the world of video gaming in a First Amendment challenge to a California law.
This article explores some of the practical impacts of the MMSEA on settlement of product liability cases. It does not address the reimbursement process vis-'-vis judgments or claims involving ongoing or future medical treatment, although some of the same principles and procedures apply.
Features
This two-part article addresses the strategic question of whether defendants sued by foreign plaintiffs for alleged foreign misconduct should pursue <i>forum non conveniens</i> dismissals.
Recent rulings of interest to you and your practice.
Features
A complete, easy-to-use listing of what's inside the newsletter.
